Literature DB >> 8368731

Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma.

D L Morton1, D S Hoon, J A Nizze, L J Foshag, E Famatiga, L A Wanek, C Chang, R F Irie, R K Gupta, R Elashoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8368731     DOI： 10.1111/j.1749-6632.1993.tb44002.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

Review 1.  Science, medicine, and the future: Cellular immunotherapy for cancer.

Authors:  A C Armstrong; D Eaton; J C Ewing
Journal:  BMJ       Date:  2001-12-01

Review 2.  Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Authors:  R G Vile; H Chong
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 3.  Immune checkpoint inhibitors in melanoma.

Authors:  Adam J Cooper; Matteo S Carlino; Richard F Kefford
Journal:  Melanoma Manag       Date:  2015-08-10

Review 4.  Prospects for the therapeutic use of anticancer vaccines.

Authors:  R S Chamberlain
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

Review 5.  Immunotherapy for melanoma: current status and perspectives.

Authors:  Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan; Francesco M Marincola; Anna Di Nardo; Filamer D Kabigting; Constantin A Dasanu
Journal:  J Immunother       Date:  2010 Jul-Aug       Impact factor: 4.456

Review 6.  Novel dendritic cell-based vaccination in late stage melanoma.

Authors:  Erika J Schneble; Xianzhong Yu; T E Wagner; George E Peoples
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.